Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Dr. Lemlem Gebremariam Aregawi , Medicinal Chemistry , PhD Candidate at University of Debrecen, Hungary

Lemlem Gebremariam Aregawi is an Ethiopian health professional and researcher currently pursuing a Ph.D. in Nutritional Sciences at the University of Debrecen, Hungary. With over a decade of academic and clinical experience, she has made significant contributions to public health, particularly in the areas of reproductive health, clinical nutrition, and functional gastrointestinal disorders. She served in academic, research, and leadership roles at Adigrat University and Mekelle University in Ethiopia before moving to Hungary on a prestigious scholarship. Her current research explores the therapeutic potential of natural compounds like ginger, and she has presented at numerous international scientific conferences. Lemlem is a published author with more than 19 scientific papers in peer-reviewed journals, and several are currently under review. She has also served as an external examiner for multiple universities. Her multidisciplinary expertise bridges laboratory science, clinical practice, and public health interventions with a strong focus on evidence-based approaches.

Professional Profile :         

Orcid 

Summary of Suitability for Award:

Dr. Lemlem Gebremariam Aregawi is an accomplished Ethiopian researcher in Nutritional Sciences, currently pursuing her Ph.D. at the University of Debrecen, Hungary. Her dedication to advancing clinical nutritional research, particularly involving ginger supplementation and gastrointestinal health, has resulted in over 19 peer-reviewed publications, with multiple clinical trials and systematic reviews in high-impact journals such as Current Therapeutic Research, Advances in Integrative Medicine, and Clinical Nutrition Open Science. Her work is pioneering in its translational focus on using natural compounds to improve public health outcomes. Given her extensive research output, commitment to evidence-based public health interventions, and international academic footprint, Dr. Lemlem Gebremariam Aregawi is a highly suitable candidate for the “Best Researcher Award”. Her work exemplifies the integration of scientific rigor, clinical relevance, and community health impact—making her an outstanding researcher deserving of global recognition.

🎓Education:

Lemlem Gebremariam Aregawi is a Ph.D. candidate in Nutritional Sciences at the University of Debrecen, Hungary (2019–present), where she is conducting clinical trial-based research focusing on dietary interventions and gastrointestinal health. She earned her Master of Public Health in Reproductive Health from Mekelle University, Ethiopia (2011–2013), gaining deep insights into maternal and child health and community-based healthcare strategies. Prior to that, she completed her Bachelor of Science in Medical Laboratory Technology at Jimma University, Ethiopia (2004–2006), where she developed solid clinical and laboratory diagnostic skills. Her academic journey is enriched with various specialized trainings from institutions such as Virge University in the Netherlands, and multiple pedagogical certifications from programs sponsored by USAID and the Ethiopian Ministry of Education. Her education reflects a rich integration of scientific research, health promotion, laboratory diagnostics, and public health practice—laying a strong foundation for her ongoing research and academic pursuits in nutritional science.

🏢Work Experience:

Lemlem Gebremariam Aregawi has accumulated diverse experience in academia, healthcare, and research over nearly two decades. Since 2019, she has been a Ph.D. researcher at the University of Debrecen, Hungary, working on clinical trials evaluating the nutritional effects of ginger. Prior to this, she served as Assistant Professor and Head of Research and Community Services at Adigrat University, Ethiopia (2014–2019), where she also taught public health and coordinated community programs. She worked briefly as a Clinical Laboratory Expert at Ayder Comprehensive Specialized Hospital, Mekelle University (2013–2014), and previously as Assistant Lecturer and Department Head at Mekelle Health Sciences College (2007–2011). Her early career began as a Medical Laboratory Technologist at Axum St. Merry Hospital (2006–2007). She has also served as an external examiner at Mekelle and Axum Universities. Lemlem’s roles span education, laboratory diagnostics, health systems strengthening, and nutritional research, reflecting her multidisciplinary expertise and leadership.

🏅Awards: 

Lemlem Gebremariam Aregawi has been recognized for her academic excellence, leadership, and commitment to public health. She is a recipient of a competitive international scholarship to pursue her Ph.D. studies in Hungary, highlighting her research potential and academic distinction. Throughout her career in Ethiopia, she earned accolades for her outstanding contributions as Head of Research and Community Services at Adigrat University. Lemlem has also been selected as an external examiner for both undergraduate and postgraduate students, reflecting her academic credibility and peer recognition. She has completed prestigious international training, including a pre-doctoral program at Virge University, Amsterdam. Additionally, she received multiple certifications from USAID-sponsored initiatives and Ethiopia’s Ministry of Education, including Training of Trainers (ToT) certifications on sexual and reproductive health, curriculum development, and biosafety. These honors and professional development achievements underscore her commitment to quality education, public health, and global scientific collaboration.

🔬Research Focus:

Lemlem Gebremariam Aregawi’s research centers on the role of nutritional interventions—particularly ginger—in preventing and managing chronic gastrointestinal conditions and metabolic disorders. As a Ph.D. candidate, she is currently engaged in clinical trials investigating the efficacy, safety, and quality-of-life impacts of ginger supplementation in patients with functional dyspepsia. Her broader interests include the therapeutic role of bioactive compounds in disease prevention, integrative medicine, reproductive health, and public health nutrition. She has authored several systematic reviews on ginger’s pharmacological effects, including its impact on body weight, gastrointestinal malignancies, diabetes mellitus, and inflammatory bowel disease. Lemlem’s work bridges clinical nutrition, public health, and biomedical sciences, offering evidence-based insights into the dietary management of chronic diseases. Her multidisciplinary approach enables her to evaluate both biological mechanisms and public health implications of nutritional therapies, with the ultimate goal of translating scientific findings into practical dietary recommendations and health policies.

Publication Top Notes:

“Ginger’s Nutritional Implication on Gastrointestinal Health”

“Evaluation of Adverse Effects and Tolerability of Dietary Ginger Supplementation in Patients with Functional Dyspepsia”

“Effects of Ginger Supplementation on Quality of Life in Patients with Functional Dyspepsia: An Open-Label, Clinical Trial”

“Preventive and Therapeutic Effects of Ginger on Bowel Disease: A Review of Clinical Trials”

“The Effect of Ginger Supplementation on the Improvement of Dyspeptic Symptoms in Patients With Functional Dyspepsia”

“Ginger Constituents and Its Effects on Gastrointestinal Malignancies: A Review of Clinical Trials”

“Assessment of Service Satisfaction and Associated Status Among Women Who Have Given Birth in Adigrat General Hospital, Ethiopia”

“Prevalence and Determinants of Modern Contraceptive Utilization Among Women in the Reproductive Age Group in Edaga-Hamus Town, Eastern Zone, Tigray Region, Ethiopia”

 

 

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Ph.D., Master’s Supervisor at Inner Mongolia Medical University, School of Basic Medical Sciences, China 

Dr. Pengwei Zhao is a Professor at the School of Basic Medical Sciences, Inner Mongolia Medical University, he serves as a master’s supervisor and holds various academic positions. He is a member of the Jiusan Society and actively contributes to scientific research as a registered reviewer for Medical Science Monitor and Chinese Journal of Tissue Engineering Research. He is also a youth editorial board member of Modern Oncology and a director of the Inner Mongolia Bioengineering Society. His research focuses on tumor immunology and pharmacological mechanisms of Mongolian medicine. Dr. Zhao has led multiple national and regional research projects, including studies on β-defensins, immune resistance, and cancer treatment mechanisms. His contributions to microbiology and oncology are widely recognized, with several impactful publications in international journals.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Pengwei Zhao, a distinguished Professor at Inner Mongolia Medical University, has made significant contributions to tumor immunology, cancer pharmacology, and Mongolian medicine. His research on β-defensins and their role in immune modulation and cancer therapy has led to groundbreaking findings, particularly in colorectal and triple-negative breast cancer (TNBC). With numerous high-impact publications, including in Pharmacogenomics Journal and World Journal of Gastrointestinal Oncology, his work is recognized globally. His ongoing National Natural Science Foundation of China project further highlights his leadership in cancer research.  Dr. Pengwei Zhao’s extensive research, innovative methodologies, and interdisciplinary approach make him an outstanding candidate for the “Best Researcher Award”. His contributions to immunotherapy, autophagy, and microbiome-related cancer treatments have the potential to shape future oncological therapies. Recognizing him with this award would honor his pioneering discoveries and impact on global cancer research.

🎓Education:

Dr. Pengwei Zhao holds a Ph.D. in Basic Medical Sciences with a specialization in tumor immunology and pharmacology. His doctoral research focused on β-defensin-mediated immune modulation and cancer therapy. He pursued his higher education at Inner Mongolia Medical University, where he developed expertise in molecular biology, pharmacology, and immunology. His early education emphasized microbiology and traditional Mongolian medicine. Dr. Zhao further enhanced his skills through postdoctoral research and collaborations with leading scientists in cancer biology. His education provided a strong foundation in oncological pharmacology, signaling pathways, and immune resistance mechanisms. He has continuously expanded his knowledge through national and international conferences, workshops, and training programs. His academic journey reflects a commitment to translational research, bridging basic science with clinical applications in cancer therapy.

🏢Work Experience:

Dr. Zhao has been a Professor at Inner Mongolia Medical University for several years, where he also serves as a Master’s Supervisor. His professional roles extend beyond teaching, as he holds multiple directorial positions in national and regional scientific societies. He is a reviewer for prestigious journals, including Medical Science Monitor and Chinese Journal of Digestive Diseases. As a youth editorial board member of Modern Oncology, he actively contributes to cancer research. He has successfully led multiple research projects funded by national and regional agencies, focusing on cancer immunology, microbiology, and Mongolian medicine-based therapies. Additionally, Dr. Zhao has conducted collaborative research on β-defensins, autophagy, and immune resistance mechanisms. His expertise in pharmacological pathways and microbial interactions has significantly advanced the understanding of cancer treatment. He has also been invited as a speaker and panelist at various oncology and pharmacology conferences.

🏅Awards: 

Dr. Pengwei Zhao has received multiple prestigious awards and honors in recognition of his contributions to tumor immunology and Mongolian medicine research. He has been honored by the Inner Mongolia Medical University for excellence in research and mentorship. His work on β-defensins and their role in cancer has earned him accolades from Inner Mongolia’s Science and Technology Department. He has also received distinguished reviewer awards from journals such as Medical Science Monitor and Chinese Journal of Tissue Engineering Research. As a key member of the Chinese Society of Ethnomedicine and Pharmacy, he has been acknowledged for his research on the pharmacological mechanisms of traditional Mongolian medicine. His contributions to microbiology and immunology have been recognized by the Inner Mongolia Microbiology Society, and he has been invited as a young committee member of the Chinese Microbiological Society’s Clinical Microbiology Professional Committee.

🔬Research Focus:

Dr. Pengwei Zhao’s research primarily focuses on tumor immunology, cancer pharmacology, and the therapeutic potential of Mongolian medicine. He investigates the molecular mechanisms of β-defensins in cancer, particularly their role in immune regulation and tumor suppression. His work explores how β-defensin-1 peptides modulate PD-1/PD-L1 immune resistance in colorectal cancer. Additionally, he studies Mongolian medicinal formulations like Sendeng-4 and their mechanisms against skin cancer. His research also extends to microbiology, analyzing how bacterial infections, such as those caused by Staphylococcus aureus and Klebsiella pneumoniae, influence lung epithelial immune responses. Dr. Zhao has also contributed significantly to understanding long noncoding RNAs (lncRNAs) and their regulatory impact on autophagy pathways in cancer. His interdisciplinary approach integrates immunology, molecular biology, and ethnopharmacology, providing novel insights into cancer therapy, host-pathogen interactions, and the development of targeted immunotherapies.

Publication Top Notes:

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis

Authors: P. Zhao, Pengwei; J. Cui, Jiaxian; X. Wang, Xiumei

Journal: Pharmacogenomics Journal

Year: 2024

Citations: 2

Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506

Authors: Y. Zhao, Yuxin; Y. Cui, Yan; X. Li, Xinhong; L. Bao, Lili; P. Zhao, Pengwei

Journal: World Journal of Gastrointestinal Oncology

Year: 2024

Citations: 3

Effect of Staphylococcus aureus in pneumonia mouse model on promotion of mBD-3 expression through ERK1/2

Authors: Yongqing Ni, Xiaoduo Bi, Pengwei Zhao

Ligilactobacillus salivarius LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice

Authors: Yang W, Li T, An S, Chen R, Zhao Y, Cui J, Zhang M, Lu J, Tian Y, Bao L, Zhao P

Journal: Microbiol Spectrum

Year: 2025

LPS Promoted HPMEC Autophagy by Suppression of the PI3K/Akt/mTOR through Inhibited TIMAP-Promoted Moesin Expression in Sepsis

Authors: Jili Wen, Pengwei Zhao, HuiJuan Ren, JunMin Wu

Journal: Journal of Biological Regulators and Homeostatic Agents

Year: 2023

 

Prof. Dr. Shivaji Thore | Medicinal Chemistry Award | Best Researcher Award

Published on by Chemistry Awards

Prof. Dr. Shivaji Thore | Medicinal Chemistry Award | Best Researcher Award

Prof. Dr. Shivaji Thore , Vinayakrao Patil Mahavidyalaya , India

Dr. Shivaji Nivrutti Thore serves as the Principal at M.S.P. Mandal’s Vinayakrao Patil Mahavidyalaya in Vaijapur, Aurangabad District. With an academic journey that began with a passion for Chemistry, he has built a remarkable career in education and research. Dr. Thore completed his Ph.D. in Chemistry from Dr. Babasaheb Ambedkar Marathwada University (BAMU), Aurangabad, has held esteemed positions, including Principal and Chairman of the Board of Studies in Chemistry at BAMU. He has over 32 years of teaching experience, 18 of which are in administrative roles. Dr. Thore is an accomplished researcher with 62 publications, an h-index of 16, and numerous books, patents, and awards to his credit, including international recognitions. His expertise spans across organic chemistry, educational administration, and quality assurance, making him a highly regarded leader in both academic and scientific circles.

Professional Profile: 

Google Scholar  

Summary of Suitability for Award:

Shivaji Nivrutti Thore demonstrates a substantial track record of research, leadership, and academic contributions that would make him a competitive candidate for the “Best Researcher Award.” As the Principal of M.S.P. Mandal’s Vinayakrao Patil Mahavidyalaya and with over 32 years of experience in teaching and administration, he brings extensive expertise in both research and institutional leadership. His academic qualifications, including a Ph.D. in Chemistry and a strong publication record with 62 research papers, underscore his depth in the field of chemistry, especially organic chemistry. He has guided 12 Ph.D. students, showing a commitment to mentoring the next generation of researchers.

🎓Education:

Dr. Shivaji Nivrutti Thore’s educational journey is grounded in his passion for the sciences, beginning with his secondary education from S.S.C. Board, Aurangabad. He pursued higher secondary studies in science at M.S.P. Mandal’s Vinayakrao Patil Mahavidyalaya, Vaijapur, and completed his HSC. He then embarked on a B.Sc. in Chemistry, Botany, and Zoology, securing first division honors from Dr. Babasaheb Ambedkar Marathwada University,  in Aurangabad. Driven by a keen interest in Organic Chemistry, he completed his M.Sc, graduating with a gold medal. Dr. Thore’s academic journey culminated in a Ph.D. in Chemistry , reflecting his deep commitment to advancing knowledge in the field. His educational foundation has paved the way for a distinguished career in academia and research.

🏢Work Experience:

Dr. Thore has over 32 years of experience in academia, beginning as a Lecturer in Chemistry , at M.S.P. Mandal’s Vinayakrao Patil Mahavidyalaya, Vaijapur. He advanced to Senior Scale Lecturer and Reader, accumulating valuable teaching and research experience. , he became Principal in the Professor Grade, and since then, he has led institutions, including Deogiri College, Aurangabad, with a total of 18 years in administrative positions. Dr. Thore’s extensive experience includes significant roles at BAMU, such as Chairman of the Board of Studies in Chemistry and Member of the Academic Council and Senate. His contributions also encompass quality assurance and accreditation processes, solidifying his reputation as a leader in institutional development and academic excellence.

🏅Awards:

Dr. Shivaji Thore has earned several prestigious awards throughout his career. In 1990, he was awarded the Gold Medal at the M.Sc. level by Dr. Babasaheb Ambedkar Marathwada University, Aurangabad. The Indian Council of Chemists recognized him as a Young Scientist in 2001, underscoring his early contributions to the field. His international acclaim includes recognition as one of the “2000 Outstanding Intellectuals of the 21st Century” by the International Biographical Center (IBC) in London , and he was subsequently named among the “Top 100 Scientists” by the same institution Dr. Shivaji Thore is also a Fellow of the International Congress of Chemistry and Environment, the American Chemical Society, and the Indian Chemical Society, acknowledging his enduring impact on the chemical sciences.

🔬Research Focus:

Dr. Shivaji Thore’s research is centered on organic chemistry, with a particular emphasis on heterocyclic compounds, medicinal chemistry, and green chemistry. His work explores efficient methodologies in synthetic organic chemistry, including catalysis and environmentally benign processes. He has contributed significantly to developing innovative compounds with potential applications in pharmaceuticals and industrial chemistry. His extensive publication record, comprising 62 articles in peer-reviewed journals, highlights his focus on sustainable chemical processes and novel synthetic techniques. Dr. Thore has also supervised multiple Ph.D. students, furthering research in these areas. His commitment to advancing knowledge is reflected in his impressive i-10 index of 25 and h-index of 16, demonstrating the impact and reach of his scientific work.

Publication Top Notes:

  •  Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives
    • Citations: 71
  • Sodium 2-(2-pyridin-3-ylethylamino) sulfonate: an efficient ligand and base for palladium-catalyzed Heck reaction in aqueous media
    • Citations: 46
  • Glyoxylic acid as catalyst: A simple selective synthesis of 1,2-disubstituted benzimidazoles in aqueous media
    • Citations: 45
  • Biological role of chalcones in medicinal chemistry
    • Citations: 42
  •  Sodium 2-(2-pyridin-3-ylethylamino) ethyl sulfonate: an efficient ligand and base for palladium-catalyzed Suzuki reaction in aqueous media
    • Citations: 37

 

 

 

 

Prof. Ahmed elhenawy | Medicinal Chemistry |Best Researcher Award

Published on by Chemistry Awards

Prof. Ahmed elhenawy | Medicinal Chemistry | Best Researcher Award

Prof. Ahmed elhenawy, Azhar unveristy, Egypt

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is a distinguished Egyptian chemist, born on December 23, 1978, in Hellwan, Egypt. With an h-index of 22 and 126 publications, he is a prominent figure in organic chemistry, particularly in peptide synthesis and drug development. Currently, he serves as an Assistant Professor at Albaha University, KSA, and as a Professor at Al-Azhar University, Egypt. With extensive teaching experience, he has guided numerous undergraduate and postgraduate students in organic chemistry. His contributions to research and academia reflect a commitment to advancing knowledge in chemical sciences, emphasizing innovative approaches to synthesizing biologically active compounds.

Professional Profile:

Google Scholar

Orcid

Summary of Suitability for Award:

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is an exemplary candidate for the “Best Researcher Awards,” primarily due to his substantial contributions to the field of organic chemistry and his commitment to advancing scientific knowledge. With an h-index of 22 and 126 publications, his research output demonstrates a high level of impact and relevance within the academic community. His specialization in peptide synthesis, particularly the development of novel amino acid derivatives with potential antimicrobial and anticancer activities, showcases his innovative approach to addressing critical health challenges.

🎓Education:

Prof. El-Henawy completed his Bachelor’s degree in Special Chemistry at Al-Azhar University in 2000. He pursued a Master’s degree in Organic Chemistry, focusing on amino acids and proteins, graduating in 2005. His doctoral research, completed in 2008, investigated new amino acid derivatives with expected biological activities. He has held various academic positions at Al-Azhar University, including Demonstrator, Assistant Lecturer, Lecturer, Associate Professor, and Professor, contributing to the department’s growth and the education of future chemists. Additionally, he has been involved in teaching at Albaha University since 2012, where he continues to inspire students through comprehensive organic chemistry courses.

🏢Work Experience:

Prof. El-Henawy has over two decades of experience in academia and research. He began his career as a Demonstrator at Al-Azhar University in 2002 and progressed to the role of Assistant Lecturer in 2005. He became a Lecturer in 2008, then an Associate Professor in 2014, and is currently a Professor. His research focuses on the synthesis of dipeptides and related compounds with potential antimicrobial and anticancer activities. He has developed expertise in various laboratory techniques, including multistep synthesis, chromatographic purification, and spectroscopic analysis. Prof. El-Henawy has supervised numerous M.Sc. and Ph.D. theses in peptide synthesis, reflecting his dedication to nurturing the next generation of chemists. His collaborative research has been presented at international conferences and published in reputable journals.

🏅Awards:

Prof. El-Henawy has received recognition for his contributions to the field of chemistry and education. His research has led to significant advancements in organic chemistry, particularly in synthesizing biologically active compounds. While specific awards are not listed, his h-index of 22 and 126 publications highlight his impact and credibility within the scientific community. His involvement in international conferences showcases his commitment to sharing knowledge and fostering collaboration among researchers. By mentoring students and guiding their research endeavors, he has played a vital role in shaping future chemists. Prof. El-Henawy’s dedication to teaching and research has earned him respect among colleagues and students alike, establishing him as a key figure in the chemistry department at both Al-Azhar University and Albaha University

🔬Research Focus:

Prof. El-Henawy’s research primarily focuses on organic chemistry, emphasizing peptide synthesis and the development of novel amino acid derivatives. His work includes synthesizing dipeptides, tri-, tetra-, and pentapeptides with antimicrobial properties. He has also explored new sulfonamide derivatives as potential antimicrobial agents and synthesized 2-amino-1,3,4-thiadiazole derivatives with anticancer potential. His research incorporates advanced laboratory techniques, such as multistep synthesis and chromatographic isolation. Prof. El-Henawy utilizes various spectroscopic methods to elucidate the structures of synthesized compounds, contributing to the understanding of their biological activities. His commitment to pharmacological research is evident in projects funded by Albaha University, focusing on the pharmacokinetics and toxicodynamics of pharmaceutical compounds. Through his innovative research, Prof. El-Henawy aims to discover new therapeutic agents that address critical health challenges.

Publication Top Notes:

  • Title: Exploring the anti-diabetic activity of benzimidazole containing Schiff base derivatives: In vitro α-amylase, α-glucosidase inhibitions and in silico studies
  • Title: Synthesis of novel thiazole derivatives containing 3-methylthiophene carbaldehyde as potent anti α-glucosidase agents: In vitro evaluation, molecular docking, dynamics, MM-GBSA …
  • Title: Experimental and computational profiling of novel bis-Schiff base derivatives bearing α-naphthalene moiety as potential tyrosinase inhibitors
  • Title: Flurbiprofen clubbed schiff’s base derivatives as potent anticancer agents: In Vitro and In Silico approach towards breast cancer
  • Title: Synthesis, anticancer, α-glucosidase inhibition, molecular docking and dynamics studies of hydrazone-Schiff bases bearing polyhydroquinoline scaffold: In vitro and in silico

 

 

 

Dr. Sphelele Sosibo|Medicinal Chemistry|Best Researcher Award

Published on by Chemistry Awards

Dr. Sphelele Sosibo|Medicinal Chemistry|Best Researcher Award

Dr. Sphelele Sosibo, North-West University, South Africa

Dr. Sphelele Cyril Sosibo is a Senior Lecturer in Organic Chemistry at North-West University in Mahikeng, South Africa. With extensive research and teaching expertise in pharmaceutical chemistry, Dr. Sosibo specializes in drug discovery for combating bacterial resistance and Alzheimer’s disease. He holds a Ph.D. in Chemistry from the University of Johannesburg, where he focused on molecular modeling of hydrolase inhibition. His research skills encompass synthesis, NMR, LCMS, and computational modeling, making significant contributions to publications on antimicrobial and anticancer compounds. Dr. Sosibo has supervised multiple graduate students, led various research projects, and actively contributes to academic and community outreach.

Professional Profile:

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Sphelele C. Sosibo is an exceptional candidate for the “Best Researcher Awards,” as demonstrated by his extensive accomplishments in both research and education. His research on antibiotic resistance and bioactive phytochemicals showcases his innovative contributions to the field of pharmaceutical chemistry. Additionally, his strong record of teaching excellence, highlighted by the Certificate of Faculty Recognition in Teaching and Learning and multiple Certificates of Merit from the University of KwaZulu-Natal, reflects his dedication to education and student success. Together, these attributes underscore his impact as a researcher and educator, making him a deserving nominee for this prestigious award.

🎓Education:

Dr. Sphelele C. Sosibo’s educational background is a testament to his dedication and expertise in the field of chemistry. He earned his Doctor of Philosophy in Chemistry from the University of Johannesburg, where he focused on molecular modeling for drug discovery related to Alzheimer’s disease and antibiotic resistance. His Master of Medical Science in Pharmaceutical Chemistry from the University of KwaZulu-Natal involved the synthesis and characterization of novel ligands, showcasing his proficiency in organic synthesis and catalysis. Furthermore, his undergraduate studies, including a Bachelor’s degree in Applied Chemistry and an Honours degree in Chemistry, provided a solid foundation in the principles of chemistry, culminating in a mini-thesis on potential antimycobacterial candidates. This robust academic journey has equipped Dr. Sosibo with the knowledge and skills necessary to contribute significantly to pharmaceutical research.

🏢Work Experience:

Dr. Sphelele C. Sosibo has a robust academic and research background, currently serving as a Senior Lecturer in Organic Chemistry at North-West University in Mahikeng, South Africa, since November 2022. He teaches both undergraduate and graduate courses while also conducting and supervising research focused on drug discovery. Prior to this, he held the position of Lecturer in Organic Chemistry at the same institution from January 2019 to November 2022, where he guided master’s and PhD researchers. His earlier experience includes a Lectureship at Durban University of Technology, where he taught analytical organic chemistry and supervised BTech research projects. Additionally, Dr. Sosibo gained international research experience as a Research Fellow at Uppsala University in Sweden and worked as a Research Assistant at the University of KwaZulu-Natal, contributing to organic chemistry research and laboratory management. His commitment to academic support was further demonstrated as a SI Leader at the University of KwaZulu-Natal, where he provided assistance to students in General Chemistry.

🏅Awards:

Dr. Sphelele C. Sosibo has received several notable awards that underscore his excellence in teaching and academic performance. He was honored with the Certificate of Faculty Recognition in Teaching and Learning from North-West University in 2021, highlighting his commitment to high-quality education. Additionally, during his time at the University of KwaZulu-Natal, he earned Certificates of Merit in Environmental Analysis III, Materials Chemistry III, and Physical Chemistry II between 2008 and 2009. Furthermore, Dr. Sosibo received Dean’s Commendations for his outstanding academic achievements in his BSc in Applied Chemistry and Cellular Biology, reflecting his dedication and excellence in the field of chemistry during his undergraduate studies.

🔬Research Focus:

Dr. Sosibo’s research primarily revolves around drug discovery, specifically targeting infections caused by resistant bacteria and Alzheimer’s disease. His work involves theoretical and bench-scale applications of organic, biochemical, and microbiological techniques. He employs various methodologies such as molecular docking, molecular dynamics simulations, and DFT calculations to investigate the interactions of bioactive phytochemicals and novel ligands with biological targets. Dr. Sosibo aims to develop innovative treatments for both communicable and non-communicable diseases, contributing to advancements in pharmaceutical chemistry.

Publication Top Notes:

  • Dual targeting approach for Mycobacterium tuberculosis drug discovery: insights from DFT calculations and molecular dynamics simulations
    • Citations: 20
  • Novel linear diamine disubstituted polycyclic ‘cage’ derivatives as potential antimycobacterial candidates
    • Citations: 18
  • Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and
    • Citations: 16
  • Catalytic asymmetric carbon–carbon bond forming reactions catalyzed by tetrahydroisoquinoline (TIQ) N, N′-dioxide ligands
    • Citations: 15
  • Impact of Pyridyl Moieties on the Inhibitory Properties of Prominent Acyclic Metal Chelators Against Metallo-β-Lactamase-Producing Enterobacteriaceae: Investigating the